However, the discussion is more nuanced than a simple yes or no
Indeed, onceweekly is the dosing frequency studied in clinical trials 8 , 9 , 18 , 21 , 22 , 23 and phase 2 trials did not test dosing intervals longer than 1 week
to reduce (or prevent) the conversion of testosterone to oestrogen (aromatase inhibitors such as anastrozole), to selectively block the action of oestrogen in breast tissue (Selective Estrogen Receptor Modulators (SERMs) such as tamoxifen) and to stimulate endogenous testosterone production following an AAS cycle (tamoxifen, clomiphene, hCG)
j) interfering with or disrupting any SkintheraServices, servers and/or networks that may be connected or related to our website, including, but not limited to, the use of any device software and/or routine to bypass the robot exclusion headers
doi:10.1016/s0304-4165(01)00235-5